A
Andrea Dalbeni
Researcher at University of Verona
Publications - 100
Citations - 1409
Andrea Dalbeni is an academic researcher from University of Verona. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 14, co-authored 67 publications receiving 878 citations.
Papers
More filters
Journal ArticleDOI
Effect of Vitamin D Supplementation on Blood Pressure: A Systematic Review and Meta-analysis Incorporating Individual Patient Data
Louise A. Beveridge,Allan D. Struthers,Faisel Khan,Rolf Jorde,Robert Scragg,Helen M. Macdonald,Jessica A. Alvarez,Rebecca S. Boxer,Andrea Dalbeni,Adam D. Gepner,Nicole M. Isbel,Thomas Larsen,Jitender Nagpal,William Petchey,Hans Stricker,Franziska Strobel,Vin Tangpricha,Laura Toxqui,M. Pilar Vaquero,Louise Wamberg,Armin Zittermann,Miles D. Witham +21 more
TL;DR: Vitamin D supplementation is ineffective as an agent for lowering BP and thus should not be used as an antihypertensive agent.
Journal ArticleDOI
Coronavirus disease 2019 (COVID-19) in children and/or adolescents: a meta-analysis.
Alessandro Mantovani,Elisabetta Rinaldi,Chiara Zusi,Giorgia Beatrice,Marco Deganello Saccomani,Andrea Dalbeni +5 more
TL;DR: Compared to adults, children and/or adolescents tend to have a mild COVID-19 course with a good prognosis, and new and consistence information on the clinical and radiological characteristics of CO VID-19 in pediatrics is provided.
Journal ArticleDOI
Platelets promote thromboinflammation in SARS-CoV-2 pneumonia
Francesco Taus,Gian Luca Salvagno,Stefania Canè,Cristiano Fava,Fulvia Mazzaferri,Elena Carrara,Varvara Petrova,Roza Maria Barouni,Francesco Dima,Andrea Dalbeni,Simone Romano,Giovanni Poli,Marco Benati,Simone De Nitto,Giancarlo Mansueto,Manuela Iezzi,Evelina Tacconelli,Giuseppe Lippi,Vincenzo Bronte,Pietro Minuz +19 more
TL;DR: Platelets in COVID-19 pneumonia are primed to spread proinflammatory and procoagulant activities in systemic circulation as well as factor XII–dependent coagulation.
Journal ArticleDOI
Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis.
TL;DR: The overall prevalence of chronic liver disease among patients with COVID‐19 disease was 3% and individuals with severe COVID-19 disease had relevant alterations of liver enzymes and coagulative profile, probably due to the innate immune response against the virus.
Journal ArticleDOI
Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19.
Salvatore Piano,Andrea Dalbeni,E. Vettore,Devis Benfaremo,Massimo Mattioli,Carmine Gambino,Viviana Framba,Lorenzo Cerruti,A. Mantovani,Andrea Martini,Michele Maria Luchetti,Roberto M. Serra,Anna Maria Cattelan,Roberto Vettor,Paolo Angeli +14 more
TL;DR: The aim of this study was to assess the prevalence, the characteristics and the clinical impact of abnormal LFTs in hospitalized, non‐critically ill patients with COVID‐19.